How to Submit NEW Protocols for hSCRO Review

Who can submit hSCRO Protocols at UCI / UCSB?

Activities that require hSCRO review at UCI and UCSB must be reviewed and approved by the UCI hSCRO Committee prior to initiation.

  • UCI is the hSCRO of record for both UCI and UCSB.
  • Review UCI's hSCRO Policies & Procedures. 
  • Complete and submit a new protocol in Zot hSCRO.
  • Please complete each section as prompted in the instruction box.
  • A Protocol Narrative must be completed and uploaded in the "Supporting Documents" Section.
    • For sections such as the background information, aims, outcome variables, methods and procedures, the investigators are encouraged to provide information listed in grant applications to ensure that the Committee has sufficient and complete information for review.
    • For each hSCRO covered material to be used, confirm that cell line provenance policy requirements have been addressed and requisite documents attached under "supporting documents". **For detailed guidance see below
  • Study Funding:
    Investigators should provide information related to the source of funding for their project.
  • Applicable Ancillary Reviews:
    It is the PI's responsibility to ensure that all required ancillary committee reviews (e.g., IRB, IBC, IACUC) are cleared / receive approval prior to initiating the research. Additional guidance
    • UCI IRB approval is required when:
      • embryos, gametes, embryos are collected at UCI (or by a UCI investigator)
      • tissue such as skin, blood, hair is collected at UCI (or by a UCI investigator) for the purpose of obtaining induced pluripotent stem cell (iPSC)
    • IACUC review is required if any of the cell products are used in animals (in vivo)
    • IBC review is required for almost all activities reviewed by hSCRO (it is possible that if a pluripotent cell product was already used at a non-UCI facility to create a final product which is composed of already differentiated cells at UCI and arrives sealed for use at UCI, it may possibly not need IBC review).
    • The PI is responsible to obtain all approvals before activities begin.
  • Location and Storage of Cells:
    Indicate the location (building and room number) for research activities (cell culture, animal experiments) and storage of materials.
  • Principal Investigator Certification:
    Lead Researcher/Principal Investigator must review the list of responsibilities which must be met to ensure adequate conduct and oversight of the study.

Cell Line Provenance Considerations:

  • Review the hSCRO Policies and procedures and the Cell Line Provenance Policy
  • Review the hSCRO Consent Checklist for Cell Line Provenance Analysis. This is the document hSCRO staff use to confirm all provenance requirements are met.
  • Material:
    Each cell line or material     such as human embryonic cell line, human induced pluripotent stem cell line, embryo, oocyte, fetal tissue or fetal-tissue derived cell lines, neural stem cells that will be used in animals must be listed individually on a separate row.
  • Non-human cell lines, cell lines that are not pluripotent (except for fetal-tissue origin multipotent stem cells or neural progenitors cells to be used in vivo) will NOT need to be listed in the Cell Tracking Table.
  • Somatic cells (fibroblasts) that have not yet been used to create pluripotent lines should NOT be included in the Cell Tracking Table. Instead, somatic cells which are stored for later use should be mentioned under "Location and Storage of Cells" section of KR Protocol.
  • Cell Line Name / ID:
    Each cell line must be listed with either their name or ID. If multiple cell lines are made from the same source (for example, if multiple iPSCs are made from the sample fibroblast line, each iPSCs line should be listed separately).
  • Supplier:
    List the name or the individual or institution that will directly supply the material. Examples are provided in the table.
  • Provenance / Source Information:
    List the specific Cell Registry, UCI or non-UCI IRB-approved protocol number under which the source material was collected or the Company and the Catalog number for somatic cells used to generate iPSCs.

    • For materials such as induced pluripotent stem cells (iPSC), fresh somatic cells, or Non-Registered Embryonic Pluripotent Cell Lines, the following documents must be uploaded:
      • A sample Consent Document
      • IRB (or equivalent ethics review) Approval Letter
      • In some instances (such as cell lines from Coriell), the approved consent form can be replaced by a statement from the providing company or institution indicating (1) specimens are de-identified, (2) no access to the key code will be granted, and (3) appropriate IRB (or equivalent) oversight was in place at the time of donation is acceptable.
    • For fetal tissue materials, upload documents as described under the webpage https://research.uci.edu/human-stem-cell-research/use-of-human-fetal-tissue-in-research/.
    • For details related to provenance documents to submit, review the Cell Provenance Policy table at https://research.uci.edu/human-stem-cell-research/guidelines-and-regulations/cell-line-provenance-policy/.
  • Registry Number:
    For human embryonic stem cells only, list the specific NIH, CIRM, UK Stem Cell Registry number.

 

Questions about the UCI hSCRO

Can't find what you are looking for? Contact: hSCRO@research.uci.edu.